An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility Allele

This publication has 26 references indexed in Scilit:

• Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study
  British Journal of Dermatology, 2000
• Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic Lesions
  Journal of Investigative Dermatology, 1998
• Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]
  Human Molecular Genetics, 1998
• Mutations of the CDKN2/p16^INK4 gene in Australian melanoma kindreds
  Human Molecular Genetics, 1995
• Mutations associated with familial melanoma impair p16INK4 function
  Nature Genetics, 1995
• Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype
  Melanoma Research, 1994
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993
• How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
  Journal of the American Academy of Dermatology, 1993
• The Dutch FAMMM family material: Clinical and genetic data
  Cytogenetic and Genome Research, 1992